Correction of a coagulopathy using recombinant factor VII before removal of an intra-aortic balloon pump.

This publication has 10 references indexed in Scilit:

• REDUCED TRANSFUSION REQUIREMENTS BY RECOMBINANT FACTOR VIIa IN ORTHOTOPIC LIVER TRANSPLANTATION
  Transplantation, 2001
• Recombinant Coagulation Factor VIIa: From the Concept to Clinical Application in Hemophilia Treatment in 2000
  Seminars in Thrombosis and Hemostasis, 2000
• The Regulation of the Factor VII-Dependent Coagulation Pathway: Rationale for the Effectiveness of Recombinant Factor VIIa in Refractory Bleeding Disorders
  Seminars in Thrombosis and Hemostasis, 2000
• SUCCESSFUL USE OF RECOMBINANT FVIIa (NOVOSEVEN^®) IN THE MANAGEMENT OF INTRACTABLE POST‐SURGICAL INTRA‐ABDOMINAL HAEMORRHAGE
  British Journal of Haematology, 1999
• Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor VII
  Transplantation Proceedings, 1999
• The effect of recombinant factor VIIa (NovoSeven???) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0
  Blood Coagulation & Fibrinolysis, 1998
• The use of recombinant factor VIIA (rFVIIA) in laparoscopic liver biopsy (LB): A pilot trial
  Gastroenterology, 1998
• Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: A preliminary study
  Gastroenterology, 1997
• SUCCESSFUL USE OF RECOMBINANT FACTOR VIIa IN PATIENT WITH SEVERE HAEMOPHILIA A DURING SYNOVECTOMY
  The Lancet, 1988
• Noncardiogenic pulmonary edema after cardiopulmonary bypass
  The American Journal of Surgery, 1984